Home > News > Company news
For ten consecutive years (2011-2020), Xingyin Pharmaceutical has been awarded the title of "Guangdong Province\'s contract-abiding and creditworthy Enterprise"
Createdate:2022-01-21

The public list of enterprises in Guangdong Province that "abide by contracts and emphasize credit" organized by the Market Supervision Administration of Guangdong Province in 2020 has been released. With good social reputation, sound contract management system and perfect service process system, Shenzhen Xingyin Pharmaceutical Co., Ltd. once again won the list.


This is the honorary title of "Guangdong Province contract-abiding and creditworthy Enterprise" for 10 consecutive years since 2011. "Guangdong Province contract and credit enterprises" is a high-standard enterprise credit evaluation approved by the Guangdong Provincial Market Supervision Administration, its evaluation standards are strict, aimed at improving the level of enterprise contract credit construction, promote enterprise integrity construction, regulate enterprise contract behavior, enhance corporate social responsibility, enhance corporate credibility, and establish industry integrity benchmark and carry out the evaluation activities.


Xingyin Pharmaceutical has been rated as "Guangdong Province\'s contract-abiding and creditworthy Enterprise" for ten consecutive years, which is the best witness of Xingyin Pharmaceutical abiding by the spirit of contract, adhering to the construction of a sound integrity management system, adhering to the integrity of the contract, and good market reputation. Xingyin Pharmaceutical always adheres to the sacred mission of "medicine for the people", cares about public health, adheres to the dedication of quality products and serves the people. The results achieved for the benefit of society. At the same time, it is also a valuable intangible asset for enterprises to enhance brand value and brand competitiveness.


In the future, Xingyin Pharmaceutical will further strengthen the principle of corporate integrity responsibility, recommitment and trustworthiness, and management according to law, and contribute to the healthy development of the pharmaceutical industry.